Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-25Clinical Trial Update: A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers. [Phase 1]
Phase 1 pharmacokinetic study comparing SB-742457 capsule and tablet formulations in healthy elderly volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease [Phase 2]
Phase 2 long-term safety extension study of SR57667B in Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2008-12-19Clinical Trial Update: Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating AVE1625 in patients with mild-to-moderate Alzheimer's disease is summarized in this update.
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Drug Interaction Study Between AZD3480 and Cytochrome P450 [Phase 1]
Phase 1 drug interaction study evaluating AZD3480 with cytochrome P450 enzymes has completed; the study encompassed contexts related to Alzh…
-
CLINICAL_TRIALS trial_result · 2008-11-05Clinical Trial Update: Drug Interaction Study With a Potential Alzheimer's Disease Compound [Phase 1]
Phase 1 drug interaction study involving a potential Alzheimer's disease compound; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
Completed clinical trial evaluating the safety of three formulations of Ketasyn given for 14 days in healthy elderly participants.
-
CLINICAL_TRIALS trial_result · 2008-10-02Clinical Trial Update: A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response. [Phase 1]
Phase 1 study in healthy subjects evaluating LY450139 (semagacestat) on amyloid beta production rate and dose response has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach? [NA]
A clinical trial evaluating systematic care for informal caregivers of dementia patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-09Clinical Trial Update: Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin [Phase 1]
Completed Phase 1 trial evaluating potential pharmacokinetic interaction between Lecozotan and Digoxin in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients [Phase 2]
The Phase 2 European trial of HF0220 in mild-to-moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [Phase 3]
This is a completed Phase 3 trial evaluating Xaliproden for mild-to-moderate Alzheimer's disease, with an 18-month assessment of efficacy.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [Phase 3]
A completed Phase 3 study evaluating Xaliproden (SR57746A) in patients with mild-to-moderate Alzheimer's-type dementia.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's [Phase 3]
Phase 3 global efficacy study of MPC-7869 for Alzheimer's disease and dementia has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol [Phase 3]
An open-label extension study of MPC-7869 for Alzheimer's disease patients who previously participated in MPC-7869 trials has been terminate…
-
CLINICAL_TRIALS trial_result · 2008-07-10Clinical Trial Update: Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients [Phase 1]
A Phase 1 study evaluating GSI-953 in healthy young volunteers and Alzheimer's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-09Clinical Trial Update: Safety Study of CTS21166 to Treat Alzheimer Disease [Phase 1]
The document reports the completion of a Phase 1 safety study evaluating CTS21166 for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2008-07-09Clinical Trial Update: Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy [Phase 1]
A Phase 1 clinical trial assessing safety, tolerability, pharmacokinetics, and 5-HT1A receptor occupancy in Alzheimer's disease has been com…
-
CLINICAL_TRIALS trial_result · 2008-05-13Clinical Trial Update: Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls [Phase 1]
Phase 1 study evaluating the radiotracer [123I] AV83 with SPECT to compare Alzheimer's disease patients against healthy controls.
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial comparing MEM 1003 to placebo in patients with mild to moderate Alzheimer's disease reports safety findings and signals of eff…
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 randomized trial comparing MEM 3454 to placebo in mild-to-moderate Alzheimer's disease completed, evaluating safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease [Phase 1, Phase 2]
A pilot study of curcumin and Ginkgo biloba for Alzheimer's disease has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects [Phase 1]
This phase 1 clinical trial update reports on using the radioiodinated imaging agent [123I] AV39 with SPECT to assess protein disposition in…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effect of Lithium and Divalproex in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating lithium and divalproex for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Alzheimer's Disease With CX516 (Ampalex) [Phase 2]
This document reports the completion of a Phase 2 trial of CX516 (Ampalex) in Alzheimer's disease (dementia).
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating whether short-term use of statins and NSAIDs alters beta-amyloid levels in Alzheimer’s disease.